Laura 2024 Asco. Pivotal studies such as the laura trial, which showcased the potential of early. Asco has issued a rapid update to its guideline on the management of stage iii.
The primary results of the global phase iii laura study, which were presented. Megan daly presents the latest rapid recommendation update to the asco management of stage iii nsclc guideline, based on data from the phase iii randomized laura trial, presented at the 2024 asco annual.